DRW Securities’s Amedisys AMED Stock Holding History

DRW Securities’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,600	Closed	-$332K	–	520
2024 Q1	$332K	Buy	+3,600	New	+$337K	0.01%	265

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

DRW Securities's AMED Position: Q2 2024 in Review

DRW Securities sold out of Amedisys (AMED) in Q2 2024, closing a stake of 3,600 shares — an estimated $332K sold.

DRW Securities first reported a position in AMED in Q1 2024 and held it in 1 quarter. The position peaked at $332K in Q1 2024. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

DRW Securities reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
DRW Securities sold 3,600 Amedisys shares in Q2 2024, an estimated $332K.
DRW Securities first reported a position in Amedisys in Q1 2024 and held it in 1 quarter.
DRW Securities's Amedisys position peaked at $332K in Q1 2024.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on DRW Securities's 13F filing for Q2 2024, filed 13 Aug 2024.